These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18807484)

  • 21. Chronic Hepatitis C virus infection in Swiss primary care practices: low case loads-high barriers to treatment?
    Overbeck K; Bruggmann P; Helbling B
    Eur J Gen Pract; 2011 Jun; 17(2):103-8. PubMed ID: 21517703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings.
    Nguyen VG; Wan K; Trinh HN; Li J; Zhang JQ; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):145-9. PubMed ID: 25014233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The elusive search for definitive evidence on routine screening for intimate partner violence.
    Spangaro J; Zwi AB; Poulos R
    Trauma Violence Abuse; 2009 Jan; 10(1):55-68. PubMed ID: 19056688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline on prevention and treatment of chronic hepatitis B in China (2005).
    ;
    Chin Med J (Engl); 2007 Dec; 120(24):2159-73. PubMed ID: 18167196
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic treatment for respiratory tract infections in Polish primary care facilities: is it time to change national guidelines or doctor prescribing behaviour?
    Chlabicz S; Pytel-Krolczuk B
    J Eval Clin Pract; 2008 Jun; 14(3):470-2. PubMed ID: 18373586
    [No Abstract]   [Full Text] [Related]  

  • 26. [Some clinical problems of chronic hepatitis B antiviral treatment].
    Gao ZL; Huang ZL; Chong YT; Chen YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):406-9. PubMed ID: 20587307
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV prevention in New Zealand--still room for improvement.
    Dickson N; Davidson OJ
    N Z Med J; 2006 Oct; 119(1243):U2250. PubMed ID: 17063190
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do guidelines preclude hepatitis B patients from receiving treatment?
    Degertekin B; Lok AS
    Hepatology; 2009 Feb; 49(2):700-1; author reply 701-2. PubMed ID: 19177583
    [No Abstract]   [Full Text] [Related]  

  • 30. [New recommendations about treatment of chronic virus hepatitis of Asian-Pacific Association for Studying the Liver (APASL): what changed in 2008?].
    Isakov VA
    Eksp Klin Gastroenterol; 2008; (6):114-5. PubMed ID: 19334435
    [No Abstract]   [Full Text] [Related]  

  • 31. [A primer on the management of antiviral resistance in chronic hepatitis B].
    Doerig C; Sahli R; Telenti A; Moradpour D
    Rev Med Suisse; 2009 Jan; 5(187):203-4, 206-8,. PubMed ID: 19271431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].
    Pierzchała W; Barczyk A; Górecka D; Sliwiński P; Zieliński J;
    Pneumonol Alergol Pol; 2010; 78(5):318-47. PubMed ID: 20703997
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evidence based medicine (EBM) in health care system and treatment of individual patient. Part II. EBM in treatment of individual patient].
    Borkowski W; Mielniczuk H
    Przegl Epidemiol; 2008; 62(3):651-9. PubMed ID: 19108530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of chronic Hepatitis B infection in the remote primary health care setting: the search for a suitable guideline.
    Cross V; Larkins S
    Aust J Rural Health; 2011 Apr; 19(2):95-100. PubMed ID: 21438952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical preventive medicine in primary care: background and practice: 1. Rationale and current preventive practices.
    Hensrud DD
    Mayo Clin Proc; 2000 Feb; 75(2):165-72. PubMed ID: 10683656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis B.
    Lok AS; McMahon BJ
    Hepatology; 2007 Feb; 45(2):507-39. PubMed ID: 17256718
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic hepatitis B infection: a workshop consensus statement and algorithm.
    McHugh JA; Cullison S; Apuzzio J; Block JM; Cohen C; Leong SL; London WT; McNellis RJ; Neubauer RL; Perrillo R; Squires R; Tarrant D; McMahon BJ
    J Fam Pract; 2011 Sep; 60(9):E1-8. PubMed ID: 21901174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.